Wound Care Market

Wound Care Market Size

The global wound care market size was estimated at USD 24.9 billion in 2024. The market is expected to grow from USD 26.3 billion in 2025 to USD 44.2 billion by 2034 at a CAGR of 5.9%. Wound care, includes dressings products which are used in contact with wound site to encourage healing of wound and to prevent further complications related to the wound. There are various kind of wound dressing which are used depending on the type of wound.

The rising prevalence of diabetes is a crucial factor which is driving market growth. For instance, according to the report from the International Diabetes Federation Atlas, their will be a substantial increase in the number of diabetic population which is from 463 million in 2019 to 578 million by 2030 and an estimated 700 million by 2045. Thus, this underscores the rising demand for effective wound care products such as advanced wound dressing, foam dressing, and hydrogel dressing driven by the increasing prevalence of diabetes related complications.

Furthermore, increasing number of surgical procedures, rising demand for wound care products, growing technological advancements in wound care products, and rise in number of trauma cases, are also the key factors contributing to the growth of the market.

Wound Care Market Trends

• Increasing demand for wound care solutions across surgical treatments can be observed globally. This has emerged as a key catalyst driving the growth of wound care products, as medical interventions have become increasingly advanced and accessible. For instance, according to the American Academy of Orthopaedic Surgeons (AAOS), owing to increasing growth in the demand for surgeries, orthopedic surgeons in the U.S. will need to either double their total joint arthroplasty (TJA) caseload or increase the number of surgeons by 10% every five years to address the rising demand by 2050.
  
• Thus, the rising emergency surgeries and elective procedures, such as trauma cases, accidents, and acute medical conditions, necessitate the demand for immediate surgical interventions, cosmetic surgeries, and others, significantly contributing to the overall surgical interventions and driving the demand for advanced wound care products.
  
• Moreover, an emerging innovation, 3D bioprinting technology, has surged the adoption of skin grafts and scaffolds to enhance the healing process of chronic wounds, burns, and diabetic ulcers through the use of customized skin grafts. This process is known as the fabrication of functional skin tissues, where bioinks containing cells, biomaterials, and growth factors are deposited in successive layers.
  
• The emergence of biopolymers such as polycaprolactone, poly(lactic-co-glycolic acid), and hydrogel materials has greatly increased their demand. Furthermore, there is a global increase in the use of bioinks that are made of living cells, biomaterials like collagen, gelatin, fibrin, chitosan, alginate, and other growth factors.
  

Wound Care Market Analysis

Based on products, the market is segmented as advanced wound dressing, surgical wound care, traditional wound care, wound therapy devices, and wound care biologics. Further, advanced wound care segment is segmented into foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings, and other advanced dressings. The advanced wound dressing segment of the market is forecasted to reach USD 14.5 billion by 2034.

• Advanced wound dressing maintain effective moisture balance, which promotes the faster tissue repair and also reduces the risk of scab formation, which can lead to the delay in healing process.
  
• Additionally, many advanced dressing includes antimicrobial agents such as silver, iodine or honey which reduces the risk of infections and supports a clean wound care environment.
  
• Furthermore, non-adherent or silicone-based dressings reduces pain during the dressing changing procedure and also prevent the damages to the newly formed tissues. Thus, escalating the market growth.
  

Based on application, the wound care market is bifurcated into chronic wounds and acute wounds. Further, the acute wounds is segmented into surgical wounds, traumatic wounds, and burns. The acute wounds segment accounted for USD 13.9 billion in 2024.

• Wound care products such as foam dressing, hydrogel dressing, film dressing are excessively used for providing immediate protection to the acute wounds, in order to reduce the risk of infection.
  
• Additionally, the adoption of advanced wound dressing products such as silicone based, or hydrogel dressing, that helps to reduce the pain and irritation which occurs during the dressing changes, is increasing during the treatment of acute wounds. This is further contributing to the growth of the segment.
  
• Moreover, acute wounds vary in size, type ranging from small cuts to surgical incisions or minor burns. Wound care products are highly versatile and can be adapted to treat various kinds of acute wounds.
  

Based on end use, the wound care market is bifurcated into hospitals, specialty clinics, home care settings, and other end users. The hospitals segment accounted for USD 9.5 billion in 2023.

• Wound care products are easily available and can be stocked in large amounts in hospitals. Additionally, hospitals ensures constant care for patients, even during emergencies or high patients inflows, by maintaining the adequate supplies of these essential products.
  
• In emergency cases where time and speed is crucial, advanced wound care products offer a quick and effective solutions for treating the wounds.
  
• Further, hospitals excessively uses antimicrobial dressing and other infection control products to minimize the risk of wound infections, thus this helps to improve the patient safety.
  
• Growing focus towards reducing hospital acquired infections (HAIs) is also further contributing to an increasing adoption of advanced wound care products across hospitals. For instance, according to the 2022 data of the World Health Organizational (WHO) report, out of every 100 patients admitted in acute care hospitals, 7 patients of high-income countries and 15 patients of lower/middle-income countries contract at least one HAI, while admitted to the hospital. As a result, the demand for advanced wound care products is increasing to curb the HAI incidence.
  

The growth of the wound care market in the U.S. is projected to reach USD 11.9 billion by 2034.

• Increasing incidence of chronic wounds are driving the demand for wound care products in the U.S. According to the American Academy of Home Care Medicine, each year in the U.S, chronic wounds affect an estimated 6.5 million people, roughly 1 in every 38 adults, costing about USD 28.1 to 96.8 billion. As a result, the demand for efficient wound care products is increasing in the U.S.
  
• Additionally, the U.S. has one of the advanced healthcare infrastructure around world, with a strong networks of hospitals, clinics, and specialized care centers.
  
• Moreover, the growing aging population and rising prevalence of diabetes further contributes to rise in chronic and acute wounds, thus the U.S. experiences high demand for wound care solutions. For instance, according to the Centers for Disease Control and Prevention, about 11.6% of U.S. population had diabetes.
  

The wound care market in UK is expected to experience significant and promising growth from 2025 to 2034.

• Increasing demand for wound care products is driven by increasing incidence of chronic wounds in the UK. According to the Public Policy Projects, 1 out of every 50 people in the UK live with a chronic wound. A vast network of healthcare resources such as the National Health Services (NHS) of UK permits all patients to have the convenient access to the essential wound care products, which drives the revenue growth in the market in the UK.
  
• According to the Public Policy Projects, wound care represent third largest expenditure after cancer and diabetes for the NHS. Wound care incurred an expense of USD 10-11 billion during 2017 to 2018. This expense increased to around USD 14-15 billion in 2023.
  
• Furthermore, government support through programs such as National Wound Care Strategy Program is further devising tools, workstreams, and pathways to promote faster wound healing through using advanced wound care products, which is expected to drive revenue growth in the market during the forecast period.
  

Japan wound care market is anticipated to witness lucrative growth between 2025 – 2034.

• Japan has one of the fastest aging populations. Chronic diseases such as diabetes, ulcers, age related skin diseases are becoming more common as the population ages. According to the World Bank Group, in Japan, people aged 65 and above contributes to about 30% of the total population in 2023. As a result, the rise in chronic diseases such as diabetes among elderlies have resulted in a surge in incidence of chronic wounds that need continuous treatment, which is fueling the demand of wound care supplies.
  
• Furthermore, owing to increasing demand for wound care, key players are focusing towards expanding their presence in Japan. For instance, MIMEDX in August 2021 announced to position Japan as one of the key market and establish MiMedx Japan, Godo Kaisha, based in Tokyo, to enter the Japanese market. Such initiatives from global players is contributing to the revenue growth in Japan market.
  

The wound care market in Saudi Arabia is expected to experience lucrative growth opportunities during the forecast period.

• Increasing demand for surgical interventions (both critical and non-critical) in Saudi Arbia has surged the demand for wound care products in the country. According to the Ministry of Health of Saudi Arabian government, about 290,000 surgeries were performed in 2022 across different regions in Saudi Arabia.
  
• Additionally, rising prevalence of chronic diseases, presence of advanced medical infrastructure, and growing adoption of wound care technologies is further driving the market growth in the country. According to the February 2024 study published by National Institutes of Health, diabetic foot complications are among the most common chronic health problem in the country, with about 81% being contributed by foot ulcers.
  

Wound Care Market Share

The market is incredibly fragmented by top five global players such as Smith & Nephew, 3M Company, Mölnlycke Health Care AB, Essity, and ConvaTec Group PLC accounting to about 40% of the market share. A key strategy for success is investing in innovation, research and development for products such as foam dressing, hydrogel dressing, advanced dressing, antimicrobial solutions and eco-friendly biodegradable materials, to improve healing, comfort, and sustainability.

Collaborations with hospitals and other healthcare providers is also crucial for expanding distribution channels and meeting the escalating demand for effective wound care solutions, particularly in managing chronic conditions. Moreover, favourable government health initiatives and increased public awareness about effective wound care solutions are driving innovation, thus strengthening the position of companies in expanding the sector.

Wound Care Market Companies

Some of the eminent market participants operating in the wound care industry include:

• 3M Company
• Advancis Medical
• B. Braun Melsungen
• Baxter International
• Coloplast
• ConvaTec Group
• Ethicon (Johnson and Johnson)
• Derma Sciences (Integra LifeSciences)
• Medline Industries
• Medtronic
• Mölnlycke Health Care
• Smith and Nephew
• URGO Medical
  

• Smith & Nephew has strong product portfolio for wound care, specifically in negative pressure wound therapy segment, which helps in driving the market expansion of the company. The company has expertise in regenerative medicines, where it offers biomaterials for chronic wound healing and collagen-based wound dressings.
  
• 3M Company has strong geographical presence, enhancing its market reach. The company primarily offers antimicrobial dressings, hydrogels, surgical tapes, and foam dressings. After the acquisition of KCI in 2019, 3M has become one of the key market player in the negative pressure wound therapy segment.
  
• ConvaTec Group PLC is one of the major player in chronic wound management and offers innovative products used for treating diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The company specifically targets hospitals and home care settings through offering cost effective products.
  

Wound Care Industry News:

• In October 2024, Smith & Nephew announced the launch of RENASYS EDGE NPWT System, a novel system for treating chronic wounds which is designed with patient convenience in mind. The system comes with a canister that is not only discreet and operates in a non-obtrusive manner while the patients carry on with their daily activities.
  
• In July 2024, Mölnlycke Health Care announced to sign a partnership agreement with MediWound Ltd., known for their next generation enzymatic therapeutics targeted towards non-surgical wound debridement. Mölnlycke Health Care invested USD 15 million, which is expected to support Mölnlycke’s Wound Care mission, that aims to helping free patients from debilitating wounds.
  
• In January 2023, CovaTec announced the launch of ConvaFoam in the U.S. This product launch helped the company to strengthen its product portfolio in advanced wound care solutions.
  
• In April 2023, 3M Veraflo Cleanse Choice Complete dressing and 3M V.A.C. Veraflo Cleanse Choice dressing received the FDA clearance for hydromechanical removal of wound debris. This FDA clearance facilitated the company to enhance their customer base and reputation.
  

The wound care market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Advanced wound dressing
  • Foam dressings
  • Hydrocolloid dressings
  • Film dressings
  • Alginate dressings
  • Hydrogel dressings
  • Collagen dressings
  • Other advanced dressings
• Surgical wound care
  • Sutures and staples
  • Tissue adhesive and sealants
  • Anti-infective dressing
• Traditional wound care
  • Medical tapes
  • Cotton
  • Bandages
  • Gauzes
  • Sponges
  • Cleansing agents
• Wound therapy devices
  • Negative pressure wound therapy
  • Oxygen and hyperbaric oxygen equipment
  • Electric stimulation devices
  • Pressure relief devices
  • Other wound therapy devices
• Wound care biologics
  • Skin substitutes
    • Biological
      • Allograft
      • Xenograft
      • Other biologicals
    • Synthetic
  • Topical agents

Market, By Application

• Chronic wounds
  • Diabetic foot ulcers
  • Pressure ulcers
  • Venous leg ulcers
  • Other chronic wounds
• Acute wounds
  • Surgical wounds
  • Traumatic wounds
  • Burns

Market, By End Use

• Hospitals
• Specialty clinics
• Home care settings
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Czech Republic
  • Netherlands
  • Denmark
  • Hungary
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE